9 December 2023 v2025.57.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsexbrli:purexbrli:sharesiso4217:GBP153388442023-12-092024-12-31153388442024-12-3115338844bus:Director12023-12-092024-12-3115338844bus:Director12024-12-3115338844bus:RegisteredOffice2023-12-092024-12-3115338844core:WithinOneYear2024-12-3115338844core:ShareCapital2024-12-3115338844core:RetainedEarningsAccumulatedLosses2024-12-3115338844core:RetainedEarningsAccumulatedLosses2023-12-092024-12-3115338844core:ShareCapital2023-12-092024-12-311533884412023-12-092024-12-3115338844countries:EnglandWales2023-12-092024-12-3115338844bus:AuditExemptWithAccountantsReport2023-12-092024-12-3115338844bus:PrivateLimitedCompanyLtd2023-12-092024-12-3115338844bus:SmallEntities2023-12-092024-12-3115338844bus:FullAccounts2023-12-092024-12-31
Company registration number:
15338844
Jomis Healthcare Ltd
Unaudited Financial Statements for the period ended
31 December 2024
Jomis Healthcare Ltd
Officers and Professional Advisers
Period ended
31 December 2024
Director
G Igbinosun
(appointed
9 December 2023
)
Registered office
88 Kentfield Drive
Bolton
Manchester
Lancashire
BL1 8FU
United Kingdom
Accountant
KAYAJ&CO LTD
34 Padbury WayLancashire
Bolton
Greater Manchester
BL2 5DQ
United Kingdom
Jomis Healthcare Ltd
Director's Report
Period ended
31 December 2024
The director presents the report and the unaudited
financial statements
of the company for the period from 9 December 2023 to 31 December 2024.

Directors

The director who served the company during the period was as follows:
G Igbinosun
(appointed
9 December 2023
)

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on
22 August 2025
and signed on behalf of the board by:
G Igbinosun
Director
Jomis Healthcare Ltd
Report to the board of directors on the preparation of the unaudited statutory financial statements of Jomis Healthcare Ltd
Period ended
31 December 2024
As described on the statement of financial position, the Board of Directors of
Jomis Healthcare Ltd
are responsible for the preparation of the
financial statements
for the period ended
31 December 2024
, which comprise the income statement, statement of financial position, statement of changes in equity and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006.
In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
KAYAJ&CO LTD
34 Padbury WayLancashire
Bolton
Greater Manchester
BL2 5DQ
United Kingdom
Date:
22 August 2025
Jomis Healthcare Ltd
Income Statement
Period ended
31 December 2024
Period from 9 Dec 2023 to 31 Dec 2024
£
Turnover
30,842
 
Gross profit
30,842
 
Administrative expenses
(28,639
 )
Operating profit
2,203
 
Profit before tax
2,203
 
Tax on profit
(419
 )
Profit for the financial period
1,784
 
The company has no other recognised items of income or expense other than the results for the period as set out above.
Jomis Healthcare Ltd
Statement of Financial Position
31 December 2024
31 Dec 2024
Note£
Current assets  
Debtors 5
2,043
 
Cash at bank and in hand
11
 
2,054
 
Creditors: amounts falling due within one year 6
(769
 )
Net current assets
1,285
 
Total assets less current liabilities 1,285  
Capital and reserves  
Called up share capital
1
 
Profit and loss account
1,284
 
Shareholders funds
1,285
 
For the period ending
31 December 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
These
financial statements
were approved by the board of directors and authorised for issue on
22 August 2025
, and are signed on behalf of the board by:
G Igbinosun
Director
Company registration number:
15338844
Jomis Healthcare Ltd
Statement of Changes in Equity
Period ended
31 December 2024
Called up share capitalProfit and loss accountTotal
£££
At
9 December 2023
 -   -   -  
Profit for the period -   1,784   1,784  
Total comprehensive income for the period -  
1,784
 
1,784
 
Issue of shares
1
 - 
1
 
Dividends declared and paid or payable during the period- 
(500
)
(500
)
Total investments by and distributions to owners
1
 
(500
)
(499
)
At
31 December 2024
1
 
1,284
 
1,285
 
Jomis Healthcare Ltd
Notes to the Financial Statements
Period ended
31 December 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
88 Kentfield Drive
,
Bolton
,
Manchester
,
Lancashire
,
BL1 8FU
, United Kingdom.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

4 Average number of employees

The average number of persons employed by the company during the period was
1
.

5 Debtors

31 Dec 2024
£
Other debtors
2,043
 

6 Creditors: amounts falling due within one year

31 Dec 2024
£
Taxation and social security
419
 
Other creditors
350
 
769